---
figid: PMC7582177__41598_2020_75114_Fig5_HTML
figlink: pmc/articles/PMC7582177/figure/Fig5/
number: F5
caption: Ventral hippocampus metabolic networks differentially affected in susceptibility
  vs resilience. Red and blue arrows indicate regulation of metabolite levels observed
  across our datasets in resilient and susceptible animals, respectively. The test
  tube icon represents an alteration observed in serum samples, as these molecules
  are excreted in urine. The hyperactive pathway through these networks experienced
  by susceptible animals is highlighted in blue. Metabolite relationships were derived
  from KEGG database and the IUBMB-Sigma-Nicholson Metabolic Pathways Chart. Solid
  black arrows represent direct metabolic reactions. Yellow boxes represent basic
  cellular functions affected by key metabolites. Molecules that survived FDR correction
  are in bold. Molecules affected by imipramine treatment are italicized. PRPP, phosphoribosyl
  pyrophosphate; GAR, glycinamide ribonucleotide; FGAR, 5′-Phosphoribosyl-N-formylglycineamide;
  AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide; IMP, inosine monophosphate;
  IDP, inosine diphosphate; XMP, xanthosine monophosphate; sAMP, succinyl adenosine
  monophosphate; AMP, adenosine monophosphate; ADP, adenosine diphosphate; ATP, adenosine
  triphosphate.
pmcid: PMC7582177
papertitle: Chronic stress and antidepressant treatment alter purine metabolism and
  beta oxidation within mouse brain and serum.
reftext: Peter J. Hamilton, et al. Sci Rep. 2020;10:18134.
pmc_ranked_result_index: '49364'
pathway_score: 0.6794382
filename: 41598_2020_75114_Fig5_HTML.jpg
figtitle: Ventral hippocampus metabolic networks differentially affected in susceptibility
  vs resilience
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7582177__41598_2020_75114_Fig5_HTML.html
  '@type': Dataset
  description: Ventral hippocampus metabolic networks differentially affected in susceptibility
    vs resilience. Red and blue arrows indicate regulation of metabolite levels observed
    across our datasets in resilient and susceptible animals, respectively. The test
    tube icon represents an alteration observed in serum samples, as these molecules
    are excreted in urine. The hyperactive pathway through these networks experienced
    by susceptible animals is highlighted in blue. Metabolite relationships were derived
    from KEGG database and the IUBMB-Sigma-Nicholson Metabolic Pathways Chart. Solid
    black arrows represent direct metabolic reactions. Yellow boxes represent basic
    cellular functions affected by key metabolites. Molecules that survived FDR correction
    are in bold. Molecules affected by imipramine treatment are italicized. PRPP,
    phosphoribosyl pyrophosphate; GAR, glycinamide ribonucleotide; FGAR, 5′-Phosphoribosyl-N-formylglycineamide;
    AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide; IMP, inosine monophosphate;
    IDP, inosine diphosphate; XMP, xanthosine monophosphate; sAMP, succinyl adenosine
    monophosphate; AMP, adenosine monophosphate; ADP, adenosine diphosphate; ATP,
    adenosine triphosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CPQ
  - BRAP
  - WDTC1
  - MFAP1
  - EMP2
  - Purine
  - Ribose-phosphate
  - ADP
  - AMP
  - Xanthosine
  - S-adenosyl
  - methionine
  - Succinyl
  - adenosine
  - Inosine
  - Nurokhanthine
  - Xanthine
  - Glutathione
  - Uric Acid
  - Fatty acid
  - Carnitine
  - fatty acids
  - Fatty Acid
  - Linoleyl-carntitine
  - Hexadecenoylcarnitine
  - Butyrylcarnitine
  - acetyl-CoA
  - Acetylphosphate
  - Myristic Acid
  - TCA
  - Benzoylcarnitine
  - Acetylcarnitine
  - Sphingosine-1-P
  - purine
genes:
- word: IDP
  symbol: LDP
  source: hgnc_alias_symbol
  hgnc_symbol: CPQ
  entrez: '10404'
- word: IMP
  symbol: IMP
  source: hgnc_alias_symbol
  hgnc_symbol: BRAP
  entrez: '8315'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: XMP
  symbol: XMP
  source: hgnc_alias_symbol
  hgnc_symbol: EMP2
  entrez: '2013'
chemicals:
- word: Purine
  source: MESH
  identifier: D011687
- word: Ribose-phosphate
  source: MESH
  identifier: C031154
- word: ADP
  source: MESH
  identifier: D000244
- word: AMP
  source: MESH
  identifier: D000249
- word: Xanthosine
  source: MESH
  identifier: C005893
- word: S-adenosyl
  source: MESH
  identifier: C016207
- word: methionine
  source: MESH
  identifier: D008715
- word: Succinyl
  source: MESH
  identifier: C035687
- word: adenosine
  source: MESH
  identifier: D000241
- word: Inosine
  source: MESH
  identifier: D007288
- word: Nurokhanthine
  source: ''
  identifier: ''
- word: Xanthine
  source: MESH
  identifier: D019820
- word: Glutathione
  source: MESH
  identifier: D005978
- word: Uric Acid
  source: MESH
  identifier: D014527
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Carnitine
  source: MESH
  identifier: D002331
- word: fatty acids
  source: MESH
  identifier: D005227
- word: Fatty Acid
  source: MESH
  identifier: D005227
- word: Linoleyl-carntitine
  source: MESH
  identifier: C059691
- word: Hexadecenoylcarnitine
  source: ''
  identifier: ''
- word: Butyrylcarnitine
  source: MESH
  identifier: C427065
- word: acetyl-CoA
  source: MESH
  identifier: D000105
- word: Acetylphosphate
  source: ''
  identifier: ''
- word: Myristic Acid
  source: MESH
  identifier: D019814
- word: TCA
  source: MESH
  identifier: C000589078
- word: Benzoylcarnitine
  source: MESH
  identifier: C050750
- word: Acetylcarnitine
  source: MESH
  identifier: D000108
- word: Sphingosine-1-P
  source: MESH
  identifier: D013110
- word: purine
  source: MESH
  identifier: D011687
diseases: []
figid_alias: PMC7582177__F5
redirect_from: /figures/PMC7582177__F5
figtype: Figure
---
